PHI with Abnormal plasma viscosity
How does this condition affect your private health insurance?
Abnorme Plasmaviskosität describes an abnormally high thickness or "stickiness" of the blood plasma, impeding microcirculation. This condition often stems from elevated levels of specific proteins like immunoglobulins (e.g., in Waldenstrom's macroglobulinemia, multiple myeloma), fibrinogen, or lipids. Symptoms, known as hyperviscosity syndrome, can include headaches, blurred vision, dizziness, fatigue, neurological deficits, bleeding, and heart failure. Untreated, it risks severe complications such as stroke, kidney failure, or irreversible vision loss. Diagnosis involves measuring plasma viscosity. Treatment focuses on reducing plasma protein levels, often via plasmapheresis, and managing the underlying cause to prevent recurrence and further damage.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months for symptomatic presentation, dependent on the acuity of the underlying condition.
Duration of Illness (Lifetime)
Chronic, often lifetime, as it typically signals an ongoing underlying disease requiring continuous management.
Cost of Treatment (Initial)
High (thousands to tens of thousands of USD), encompassing diagnostics, initial symptomatic treatment (e.g., plasmapheresis), and early management of the underlying cause.
Cost of Treatment (Lifetime)
Very high (tens of thousands to hundreds of thousands of USD), due to chronic disease management, repeated treatments, and potential complications over a lifetime.
Mortality Rate
Moderate to high; directly depends on the severity and treatability of the underlying disease. Acute, severe, untreated hyperviscosity crisis carries a high risk of fatality.
Risk of Secondary Damages
High, including neurological impairment (e.g., stroke), vision loss, renal dysfunction, and hemorrhagic complications, especially if diagnosis or treatment is delayed.
Probability of Full Recovery
Low, as it is typically a manifestation of a chronic underlying disease (e.g., plasma cell dyscrasias); complete recovery hinges on the curability of the primary condition.
Underlying Disease Risk
Very high (nearly 100%), as abnormal plasma viscosity is almost always a consequence of underlying conditions such as plasma cell dyscrasias, autoimmune diseases, or severe inflammatory states.